Literature DB >> 4877964

The discovery and development of amphotericin B.

J D Dutcher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4877964     DOI： 10.1378/chest.54.supplement_1.296

Source DB:  PubMed          Journal:  Dis Chest        ISSN： 0096-0217


× No keyword cloud information.
  27 in total

1.  Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.

Authors:  Samusi A Adediran; Timothy P Day; Diptesh Sil; Matthew R Kimbrell; Hemamali J Warshakoon; Subbalakshmi S Malladi; Sunil A David
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

Review 2.  Exploiting mitochondria as targets for the development of new antifungals.

Authors:  Dongmei Li; Richard Calderone
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

3.  Long-term venous access in rhesus monkeys.

Authors:  P D Hoeprich; B M Wolfe; C Jerome; D A Olson; A C Huston
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

Review 4.  Current concepts in antifungal pharmacology.

Authors:  Russell E Lewis
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

Review 5.  Applications of Nonenzymatic Catalysts to the Alteration of Natural Products.

Authors:  Christopher R Shugrue; Scott J Miller
Journal:  Chem Rev       Date:  2017-06-05       Impact factor: 60.622

6.  A complex game of hide and seek: the search for new antifungals.

Authors:  Huy X Ngo; Sylvie Garneau-Tsodikova; Keith D Green
Journal:  Medchemcomm       Date:  2016-05-17       Impact factor: 3.597

7.  The rise of an opportunistic infection called "Invasive Zygomycosis".

Authors:  Abdelkarim Waness; Ghuzayel Al Dawsari; Hamdan Al Jahdali
Journal:  J Glob Infect Dis       Date:  2009-07

Review 8.  The Mechanistic Targets of Antifungal Agents: An Overview.

Authors:  Tryphon K Mazu; Barbara A Bricker; Hernan Flores-Rozas; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 9.  Treatment of invasive candidiasis in immunocompromised pediatric patients.

Authors:  Brian T Fisher; Theoklis E Zaoutis
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  SQ109 inhibits proliferation of Leishmania donovani by disruption of intracellular Ca2+ homeostasis, collapsing the mitochondrial electrochemical potential (ΔΨm) and affecting acidocalcisomes.

Authors:  Zain Gil; Nathalia Martinez-Sotillo; Andrea Pinto-Martinez; Fabiola Mejias; Juan Carlos Martinez; Ivan Galindo; Eric Oldfield; Gustavo Benaim
Journal:  Parasitol Res       Date:  2020-01-02       Impact factor: 2.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.